(Q34165509)

31 July 2017

Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids (English)

1 reference

Katherine A Lyseng-Williamson

31 July 2017

1 reference

object named as

Katherine A Lyseng-Williamson

series ordinal

1

0 references

Caroline M Perry

series ordinal

2

object named as

Caroline M Perry

1 reference

31 July 2017

1 January 2003

1 reference

31 July 2017

1 reference

31 July 2017

63

1 reference

31 July 2017

71-100

1 reference

31 July 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200363010-00005

31 July 2017

0 references

cites work

Haemorrhoids: pathology, pathophysiology and aetiology

1 reference

12 December 2020

Protective effect of a purified flavonoid fraction against reactive oxygen radicals. In vivo and in vitro study

1 reference

12 December 2020

Clinical efficacy of micronized purified flavonoid fraction: an overview

1 reference

12 December 2020

Laser Doppler and transcutaneous oximetry: modern investigations to assess drug efficacy in chronic venous insufficiency

1 reference

12 December 2020

Daflon 500 mg in the treatment of hemorrhoidal disease: a demonstrated efficacy in comparison with placebo

1 reference

12 December 2020

Socioeconomic impact of chronic venous insufficiency and leg ulcers

1 reference

12 December 2020

Diosmin-induced increase in sensitivity to Ca2+ of the smooth muscle contractile apparatus in the rat isolated femoral vein

1 reference

12 December 2020

Venous ulcer reappraisal: insights from an international task force. Veines International Task Force

1 reference

12 December 2020

Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency

1 reference

12 December 2020

The nature of haemorrhoids

1 reference

12 December 2020

Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting

1 reference

12 December 2020

Consensus paper on venous leg ulcer. The Alexander House Group

1 reference

12 December 2020

Investigation of chronic venous insufficiency: A consensus statement (France, March 5-9, 1997).

1 reference

12 December 2020

Effect of a micronized purified flavonoid fraction on in vivo platelet functions in the rat

1 reference

12 December 2020

Therapeutic approach to chronic venous insufficiency and its complications: place of Daflon 500 mg.

1 reference

12 December 2020

Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders

1 reference

12 December 2020

Micronized flavonoid therapy in internal hemorrhoids of pregnancy

1 reference

12 December 2020

The pathogenesis of hemorrhoids

1 reference

12 December 2020

Neutrophil activation and mediators of inflammation in chronic venous insufficiency

1 reference

12 December 2020

1 reference

12 December 2020

Chronic venous insufficiency of the lower limbs and its socio-economic significance

1 reference

12 December 2020

Update on chronic-venous-insufficiency-induced inflammatory processes

1 reference

12 December 2020

Pharmacologic treatment of venous leg ulcers.

1 reference

12 December 2020

Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg

1 reference

12 December 2020

Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon

1 reference

12 December 2020

Postphlebitic Syndrome and General Surgery: An Epidemiologic Investigation

1 reference

12 December 2020

Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease.

1 reference

12 December 2020

Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids.

1 reference

12 December 2020

Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders

1 reference

12 December 2020

Benefit of a 2-month treatment with a micronized, purified flavonoidic fraction on venous ulcer healing. A randomized, double-blind, controlled versus placebo trial.

1 reference

12 December 2020

Chronic venous insufficiency and venous leg ulceration

1 reference

12 December 2020

Effect of fiber supplements on internal bleeding hemorrhoids

1 reference

12 December 2020

Micronized purified flavonidic fraction compared favorably with rubber band ligation and fiber alone in the management of bleeding hemorrhoids: randomized controlled trial

1 reference

12 December 2020

Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682 (Daflon 500 mg) and alpha-tocopherol

1 reference

12 December 2020

Mediators involved in inflammation: effects of Daflon 500 mg on their release

1 reference

12 December 2020

Effects of Oral Administration of Purified Micronized Flavonoid Fraction on Increased Microvascular Permeability Induced by Various Agents and on Ischemia/Reperfusion in the Hamster Cheek Pouch

1 reference

12 December 2020

Effect of chronic treatment with a purified flavonoid fraction on inflammatory granuloma in the rat. Study of prostaglandin E2 and F2 alpha and thromboxane B2 release and histological changes.

1 reference

12 December 2020

Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ)

1 reference

12 December 2020

Adhesion molecule expression in postischemic microvascular dysfunction: activity of a micronized purified flavonoid fraction

1 reference

12 December 2020

Oral administration of purified micronized flavonoid fraction suppresses leukocyte adhesion in ischemia-reperfusion injury: in vivo observations in the hamster skin fold.

1 reference

12 December 2020

Effects of Daflon 500 mg* on haemoconcentration and alterations of white blood cell count elicited by the upright position in anaesthetized dogs.

1 reference

12 December 2020

Morphologic and functional changes of the microlymphatic network in patients with advancing stages of primary lymphedema

1 reference

12 December 2020

Leukocyte adhesion after oxidant challenge in the hamster cheek pouch microcirculation

1 reference

12 December 2020

Horse-chestnut seed extract for chronic venous insufficiency. A criteria-based systematic review

1 reference

12 December 2020

Systemic treatment of venous leg ulcers with high doses of pentoxifylline: efficacy in a randomized, placebo-controlled trial

1 reference

12 December 2020

Efficacy and Safety of a Butcher’s Broom Preparation (Ruscus aculeatus L. Extract) Compared to Placebo in Patients Suffering from Chronic Venous Insufficiency

1 reference

12 December 2020

Leukocyte activation in patients with venous insufficiency

1 reference

12 December 2020

The human saphenous vein in pharmacology: effect of a new micronized flavonoidic fraction (Daflon 500 mg) on norepinephrine induced contraction

1 reference

12 December 2020

Effects of oral administration of different doses of purified micronized flavonoid fraction on microvascular reactivity after ischaemia/reperfusion in the hamster cheek pouch

1 reference

12 December 2020

The inflammatory reaction during venous hypertension in the rat.

1 reference

12 December 2020

Prospective randomized controlled trial of a micronized flavonidic fraction to reduce bleeding after haemorrhoidectomy

1 reference

12 December 2020

Socio-economic impact of chronic venous insufficiency. An underestimated public health problem.

1 reference

12 December 2020

The epidemiology of varicose veins: the Framingham Study

1 reference

12 December 2020

Chronic leg ulcers: an underestimated problem in primary health care among elderly patients

1 reference

12 December 2020

Fifteen-year results of ambulatory compression therapy for chronic venous ulcers.

1 reference

12 December 2020

Intravenous prostaglandin E1 in the treatment of venous ulcers--a double-blind, placebo-controlled trial

1 reference

12 December 2020

Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids

1 reference

12 December 2020

Capillary filtration and ankle edema in patients with venous hypertension: effects of Daflon

1 reference

12 December 2020

Effects of the phlebotropic drug Daflon 500 mg on postischemic reperfusion injury in striated skin muscle: a histomorphologic study in the hamster

1 reference

12 December 2020

Daflon 500 mg depresses bradykinin-ischemia-induced microvascular leakage of FITC dextran in rat cremaster muscle

1 reference

12 December 2020

A systematic review of compression treatment for venous leg ulcers

1 reference

12 December 2020

Role of warm-water bath in anorectal conditions. The "thermosphincteric reflex".

1 reference

12 December 2020

Effects of Daflon 500 mg on bovine vessels contractility

1 reference

12 December 2020

The prevalence of hemorrhoids and chronic constipation. An epidemiologic study

1 reference

12 December 2020

Pharmacokinetics and metabolism of oral diosmin in healthy volunteers

1 reference

12 December 2020

Pharmacologic properties of Daflon 500 mg

1 reference

12 December 2020

Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study

1 reference

12 December 2020

Plasma VEGF as a marker of therapy in patients with chronic venous disease treated with oral micronised flavonoid fraction - a pilot study

1 reference

12 December 2020

Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency

1 reference

12 December 2020

Monocyte infiltration into venous valves

1 reference

12 December 2020

Prevalence and risk factors of chronic venous insufficiency.

1 reference

12 December 2020

Long-term prognosis for patients with chronic leg ulcers: a prospective cohort study.

1 reference

12 December 2020

The relation of venous ulceration with ambulatory venous pressure measurements

1 reference

12 December 2020

Nonsurgical treatment options for internal hemorrhoids.

1 reference

12 December 2020

Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form

1 reference

12 December 2020

An original microhaemorheological approach to the pharmacological effects of Daflon 500 mg in severe chronic venous insufficiency.

1 reference

12 December 2020

Venous elasticity after treatment with Daflon 500 mg

1 reference

12 December 2020

Pharmacologic aspects of a phlebotropic drug in CVI-associated edema

1 reference

12 December 2020

Endothelial activation response to oral micronised flavonoid therapy in patients with chronic venous disease--a prospective study

1 reference

12 December 2020

High-fiber diet reduces bleeding and pain in patients with hemorrhoids: a double-blind trial of Vi-Siblin

1 reference

12 December 2020

Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: a pilot study

1 reference

12 December 2020

A long term treatment with a venotropic drug. Results on efficacy and safety of Daflon 500 mg in chronic venous insufficiency

1 reference

12 December 2020

A double-blind, placebo-controlled trial of a new veno-active flavonoid fraction (S 5682) in the treatment of symptomatic capillary fragility.

1 reference

12 December 2020

Study of capillary filtration by double labelling I131-albumin and Tc99m red cells. Application to the pharmacodynamic activity of Daflon 500 mg

1 reference

12 December 2020

Randomized clinical trial of micronized flavonoids in the early control of bleeding from acute internal haemorrhoids

1 reference

12 December 2020

Oxpentifylline treatment of venous ulcers of the leg

1 reference

12 December 2020

Doxium 500 in chronic venous insufficiency: a double-blind placebo controlled multicentre study

1 reference

12 December 2020

Risk factors for leg ulcer recurrence: a randomized trial of two types of compression stocking

1 reference

12 December 2020

Clinical practice guidelines for the treatment of hemorrhoid disease

1 reference

12 December 2020

10.2165/00003495-200363010-00005

Identifiers

DOI

1 reference

PubMed ID

12487623

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

12487623